Anil Kumar

5PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersMolecular targetsInnate immunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 11, 2025
Molecular Sentinels: Unveiling the Role of Sirtuins in Prostate Cancer Progression.

Surbhi Chouhan, Naoshad Muhammad, Darksha Usmani

|Dec 17, 2024
Sirtuins as Key Regulators in Pancreatic Cancer: Insights into Signaling Mechanisms and Therapeutic Implications.

Surbhi Chouhan, Anil Kumar, Naoshad Muhammad

|May 22, 2023
Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia.

Anil Kumar, Adeleh Taghi Khani, Caroline Duault

|Jun 02, 2021
Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia.

Caroline Duault, Anil Kumar, Adeleh Taghi Khani

|Jan 05, 2020
IL-3 Receptor Expression on Activated Human Th Cells Is Regulated by IL-4, and IL-3 Synergizes with IL-4 to Enhance Th2 Cell Differentiation.

Anil Kumar, Lekha Rani, Suhas T Mhaske

Pageof 1

Frequent Collaborators

2 joint publications

Caroline Duault

2 joint publications

Sarah K Tasian

2 joint publications

Srividya Swaminathan

2 joint publications

Tabish H Khan